Market Capitalization (Millions $) |
283 |
Shares
Outstanding (Millions) |
54 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-4 |
Cash Flow (TTM) (Millions $) |
-1 |
Capital Exp. (TTM) (Millions $) |
0 |
Capstone Therapeutics Corp.
Capstone Therapeutics Corp. is a biopharmaceutical company focusing on the development and commercialization of novel therapeutic products for the treatment of serious medical conditions. Founded in 1987 and headquartered in Arizona, United States, the company primarily works on developing proprietary technologies and drug candidates for various diseases, including orphan drug indications. They aim to address unmet medical needs and improve the lives of patients through their innovative therapeutic solutions. Capstone Therapeutics Corp. engages in research collaborations, licensing agreements, and strategic partnerships to advance their drug development programs.
|